Cargando…

Are Alternative Strategies Required to Accelerate the Global Elimination of Lymphatic Filariasis? Insights From Mathematical Models

BACKGROUND: With the 2020 target year for elimination of lymphatic filariasis (LF) approaching, there is an urgent need to assess how long mass drug administration (MDA) programs with annual ivermectin + albendazole (IA) or diethylcarbamazine + albendazole (DA) would still have to be continued, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stolk, Wilma A, Prada, Joaquin M, Smith, Morgan E, Kontoroupis, Periklis, de Vos, Anneke S, Touloupou, Panayiota, Irvine, Michael A, Brown, Paul, Subramanian, Swaminathan, Kloek, Marielle, Michael, E, Hollingsworth, T Deirdre, de Vlas, Sake J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Supplement Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982795/ https://www.ncbi.nlm.nih.gov/pubmed/29860286 http://dx.doi.org/10.1093/cid/ciy003

Ejemplares similares

Elimination or Resurgence: Modelling Lymphatic Filariasis After Reaching the 1% Microfilaremia Prevalence Threshold
por: Prada, Joaquin M, et al.
Publicado: (2020)

Quantifying the value of surveillance data for improving model predictions of lymphatic filariasis elimination
por: Michael, Edwin, et al.
Publicado: (2018)

Delays in lymphatic filariasis elimination programmes due to COVID-19, and possible mitigation strategies
por: Prada, Joaquín M, et al.
Publicado: (2021)

Comparing antigenaemia- and microfilaraemia as criteria for stopping decisions in lymphatic filariasis elimination programmes in Africa
por: Stolk, Wilma A., et al.
Publicado: (2022)

Predicting lymphatic filariasis transmission and elimination dynamics using a multi-model ensemble framework
por: Smith, Morgan E., et al.
Publicado: (2017)

Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modelling
por: Stolk, Wilma A, et al.
Publicado: (2006)

Statistical methods for linking geostatistical maps and transmission models: Application to lymphatic filariasis in East Africa
por: Touloupou, Panayiota, et al.
Publicado: (2022)

Progress towards lymphatic filariasis elimination in Ghana from 2000-2016: Analysis of microfilaria prevalence data from 430 communities
por: Biritwum, Nana Kwadwo, et al.
Publicado: (2019)

Modeling the Impact and Costs of Semiannual Mass Drug Administration for Accelerated Elimination of Lymphatic Filariasis
por: Stolk, Wilma A., et al.
Publicado: (2013)

Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators
por: Jambulingam, Purushothaman, et al.
Publicado: (2016)

Standardisation of lymphatic filariasis microfilaraemia prevalence estimates based on different diagnostic methods: a systematic review and meta-analysis
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2020)

Understanding heterogeneities in mosquito-bite exposure and infection distributions for the elimination of lymphatic filariasis
por: Irvine, Michael A., et al.
Publicado: (2018)

Evaluating the Evidence for Lymphatic Filariasis Elimination
por: Davis, Emma L., et al.
Publicado: (2019)

The effect of assortative mixing on stability of low helminth transmission levels and on the impact of mass drug administration: Model explorations for onchocerciasis
por: de Vos, Anneke S., et al.
Publicado: (2018)

The impact of mass drug administration expansion to low onchocerciasis prevalence settings in case of connected villages
por: de Vos, Anneke S., et al.
Publicado: (2021)

Understanding the relationship between prevalence of microfilariae and antigenaemia using a model of lymphatic filariasis infection
por: Irvine, Michael A., et al.
Publicado: (2016)

Mapping and monitoring for a lymphatic filariasis elimination program: a systematic review
por: Srividya, Adinarayanan, et al.
Publicado: (2019)

The history of the elimination of lymphatic filariasis in China
por: De-jian, Sun, et al.
Publicado: (2013)

How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2021)

Elimination of Lymphatic Filariasis in The Gambia
por: Rebollo, Maria P., et al.
Publicado: (2015)

Modelling the Impact of Vector Control on Lymphatic Filariasis Programs: Current Approaches and Limitations
por: Davis, E L, et al.
Publicado: (2021)

Modelling strategies to break transmission of lymphatic filariasis - aggregation, adherence and vector competence greatly alter elimination
por: Irvine, M. A., et al.
Publicado: (2015)

Mathematical models for lymphatic filariasis transmission and control: Challenges and prospects
por: Swaminathan, Subramanian, et al.
Publicado: (2008)

Pacific collaboration to eliminate lymphatic filariasis
por: Ichimori, Kazuyo, et al.
Publicado: (2005)

Understanding the relationship between egg- and antigen-based diagnostics of Schistosoma mansoni infection pre- and post-treatment in Uganda
por: Prada, Joaquín M., et al.
Publicado: (2018)

Diethylcarbamazine citrate-fortified salt for lymphatic filariasis elimination in India
por: Sabesan, S., et al.
Publicado: (2022)

Economic evaluations of lymphatic filariasis interventions: a systematic review and research needs
por: Gedge, Lukyn M., et al.
Publicado: (2018)

Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis
por: Stolk, Wilma A., et al.
Publicado: (2015)

Lymphatic filariasis in Brazil: epidemiological situation and outlook for elimination
por: Fontes, Gilberto, et al.
Publicado: (2012)

Progress on elimination of lymphatic filariasis in Sierra Leone
por: Koroma, Joseph B., et al.
Publicado: (2018)

Elimination of lymphatic filariasis in South East Asia
por: Specht, Sabine, et al.
Publicado: (2019)

Defining a prevalence level to describe the elimination of Lymphatic Filariasis (LF) transmission and designing monitoring & evaluating (M&E) programmes post the cessation of mass drug administration (MDA)
por: Collyer, Benjamin S., et al.
Publicado: (2020)

Diversity and transmission competence in lymphatic filariasis vectors in West Africa, and the implications for accelerated elimination of Anopheles-transmitted filariasis
por: de Souza, Dziedzom K, et al.
Publicado: (2012)

Lymphatic filariasis: A view at pathological diversity
por: Mahalingashetti, Prashant Basavaraj, et al.
Publicado: (2014)

Predictive Value of Ov16 Antibody Prevalence in Different Subpopulations for Elimination of African Onchocerciasis
por: Coffeng, Luc E, et al.
Publicado: (2019)

MDA—Lymphatic Filariasis
por: Ichimori, Kazuyo
Publicado: (2014)

Urban lymphatic filariasis
por: Simonsen, Paul E., et al.
Publicado: (2012)

Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997–2006
por: Allen, Tammy, et al.
Publicado: (2017)

Defining the cost of the Egyptian lymphatic filariasis elimination programme
por: Ramzy, Reda MR, et al.
Publicado: (2005)

Population Migration: Implications for Lymphatic Filariasis Elimination Programmes
por: Ramaiah, K. D.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_am85fvl6uhqsgajqka0c4s4thn